Anagrelide Hydrochloride (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Anagrelide Hydrochloride drug offered from Avera McKennan Hospital. This Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | Anagrelide Hydrochloride |
| SUBSTANCE NAME: | ANAGRELIDE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-07-15 |
| END MARKETING DATE: | 0000-00-00 |
Anagrelide Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Anagrelide Hydrochloride from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2015-07-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-5241_6664d6f6-5932-4eaf-982b-7dd94a6638c7 |
| PRODUCT NDC: | 69189-5241 |
| APPLICATION NUMBER: | ANDA076468 |
Other ANAGRELIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
